BioCryst Pharmaceuticals, Inc.
(NASDAQ : BCRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.41%183.731.1%$863.66m
GILDGilead Sciences, Inc.
-0.30%80.700.9%$827.80m
CELGCelgene Corporation
1.04%94.821.2%$768.75m
JUNOJuno Therapeutics, Inc.
1.98%86.6613.5%$580.30m
BIIBBiogen Inc.
0.36%288.481.2%$511.77m
REGNRegeneron Pharmaceuticals, Inc.
-1.24%319.042.7%$395.78m
VRTXVertex Pharmaceuticals Incorporated
-1.61%158.391.9%$353.57m
ALXNAlexion Pharmaceuticals, Inc.
-0.95%117.722.0%$254.18m
NKTRNektar Therapeutics
0.84%84.156.0%$249.13m
ILMNIllumina, Inc.
0.18%226.983.5%$231.13m
BLUEBluebird Bio, Inc.
2.18%209.9316.1%$196.14m
AAgilent Technologies, Inc.
1.51%72.161.5%$178.27m
INCYIncyte Corporation
0.35%85.812.5%$154.66m
BMRNBioMarin Pharmaceutical Inc.
1.05%84.734.4%$122.45m
EXASExact Sciences Corporation
-0.24%47.9026.0%$117.89m

Company Profile

BioCryst Pharmaceuticals, Inc. engages in the research, development, and commercialization of biopharmaceutical products. Its portfolio includes Rapivab, Kallikrein inhibitors, and BCX4430. These drugs intend to treat influenza and hereditary angioedema. The company was founded in 1986 and is headquartered in Durham, NC.